克服感冒瘤:免疫检查点抑制剂的组合策略
Peng Ouyang1, Lijuan Wang2, Jianlong Wu1
1Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Frontiers in immunology
|March 28, 2024
概括
免疫检查点抑制剂 (ICI) 在患者中显示出有限的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 免疫检查点抑制剂 (ICI) 已经推进了癌症治疗.
- 然而,由于免疫逃避,大多数"冷"瘤对ICI没有反应.
- 了解冷瘤的耐药性是有效的癌症治疗的关键.
研究的目的:
- 探索"冷"瘤转变为"热"瘤的过程.
- 确定影响瘤T细胞透的关键因素.
- 为了提高ICI治疗非响应性瘤的疗效.
主要方法:
- 审查关于瘤免疫逃避机制的当前研究.
- 对瘤免疫概况的诊断技术和生物标志物的分析.
- 探索增强T细胞激活和定位的策略.
主要成果:
- 感冒瘤缺乏T细胞透,使ICI治疗无效.
- 免疫逃避机制对ICI耐药性有显著的贡献.
- 正在探索诸如双特异性抗体和CAR-T细胞等策略.
结论:
- 将"冷"瘤转化为"热"瘤对于改善ICI治疗至关重要.
- 准T细胞透和激活对于治疗感冒瘤至关重要.
- 对影响T细胞透的因素进行进一步的研究至关重要.
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907
Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363


